Subhi Sarna sold nVision Medical for $275 million in 2018. Now she's been named Y Combinator's first-ever group partner focused on healthcare and biotech as part of a pandemic-fueled deeper focus from the startup accelerator.
Y Combinator Names Surbhi Sarna Its First-Ever Partner For Healthcare And Biotech
Forbes - 26 Oct 2021 15:00
Subhi Sarna sold nVision Medical for $275 million in 2018. Now she's been named Y Combinator's first-ever group partner focused on healthcare and biotech as part of a pandemic-fueled deeper focus from the startup accelerator.
Share this Article
Recommended